Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Significant Growth in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large growth in short interest in June. As of June 30th, there was short interest totaling 812 shares, a growth of 7,281.8% from the June 15th total of 11 shares. Based on an average daily trading volume, of 3,083 shares, the short-interest ratio is presently 0.3 days. Currently, 0.2% of the shares of the company are sold short.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Osaic Holdings Inc. lifted its holdings in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after purchasing an additional 597 shares in the last quarter. Comprehensive Wealth Management LLC grew its holdings in Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after buying an additional 12,859 shares in the last quarter. Finally, Susquehanna International Group LLP grew its holdings in Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Performance

BOUT stock traded down $0.35 during midday trading on Friday, reaching $46.66. 1,926 shares of the company’s stock traded hands, compared to its average volume of 4,263. The firm has a market capitalization of $16.33 million, a PE ratio of 28.69 and a beta of 1.03. The company has a 50-day moving average price of $46.89 and a two-hundred day moving average price of $42.29. Innovator IBD Breakout Opportunities ETF has a 52 week low of $35.05 and a 52 week high of $49.41.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.